@article{article, title  = {{Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{https://doi.org/10.1097/tp.0000000000005065 }},

 year = {{2024}},

 month = {{10}},

 author = {{Brook MO and Hennessy C and Hester J and Hammad S and Alzhrani A and Rombach I and Dutton S and Lombardi G and Wood KJ and Friend P and Harden PN et al}},

 doi = {{10.1097/tp.0000000000005065}},

 volume = {{108}},

 journal = {{Transplantation}},

 issue = {{11}},

 pages = {{2278-2286}},

 note = {{Accessed on 2025/05/21}}}